サマリー

中東・アフリカの植物性飼料添加物市場は、2022年の5,411万米ドルから2030年には1億2,030万米ドルに達し、2023年から2030年の予測期間中に年平均成長率8.4％で成長すると予測されている。

市場区分
中東およびアフリカのフィトジェニック飼料添加物市場：タイプ別（エッセンシャルオイル、フラボノイド、サポニン、オレオレジン、タンニン、その他）、動物飼料のタイプ別（家禽飼料、反芻動物飼料、水生飼料、豚飼料、その他）、供給源別（ハーブとスパイス）、形態別（乾燥と液体）、機能別（パフォーマンス向上剤、抗菌特性、嗜好性向上剤、消化促進剤、その他）、国別（サウジアラビア、U.国別（サウジアラビア, オマーン, クウェート, カタール, 南アフリカ, その他の中東・アフリカ地域） - 2030年までの産業動向と予測
中東・アフリカのフィトジェニック飼料添加物市場ダイナミクスの概要

ドライバー

- 抗生物質飼料添加物に対する厳しい規制

抑制要因

- 価格変動は動物栄養セクターの利益率低下につながる

機会

- 有機水産養殖の成長により、有機飼料添加物の関与が増加する。
市場プレーヤー

中東・アフリカの植物性飼料添加物市場で事業を展開している主な市場プレーヤーは以下の通りである：
- カーギル社
- DSM社
- ケミン・インダストリーズ社
- ADM
- ニュートレコ
- ナチュラルレメディーズ
- ヒマラヤ・ウェルネス・カンパニー
- ヴィナヤック・インジェディメンツインド
- シルバチームS.p.a.
- フィトバイオティクス社
- テガサ
- ミアビットGMBH
- インドハーブ
- ドストファーム社
- 英国馬飼料
- オルファ
- イグソール
- グラマックインターナショナルプライベートリミテッド
- ノルフィード

ページTOPに戻る

目次

TABLE OF CONTENTS
1 INTRODUCTION 39
1.1 OBJECTIVES OF THE STUDY 39
1.2 MARKET DEFINITION 39
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA PHYTOGENIC FEED ADDITIVES MARKET 39
1.4 LIMITATIONS 40
1.5 MARKETS COVERED 41
2 MARKET SEGMENTATION 44
2.1 MARKETS COVERED 44
2.2 GEOGRAPHICAL SCOPE 45
2.3 YEARS CONSIDERED FOR THE STUDY 46
2.4 CURRENCY AND PRICING 46
2.5 DBMR TRIPOD DATA VALIDATION MODEL 47
2.6 MULTIVARIATE MODELLING 50
2.7 TREATMENT LIFELINE CURVE 50
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 51
2.9 DBMR MARKET POSITION GRID 52
2.10 SECONDARY SOURCES 54
2.11 ASSUMPTIONS 54
3 EXECUTIVE SUMMARY 55
4 PREMIUM INSIGHTS 57
4.1 FACTORS INFLUENCING PURCHASE DECISION 58
4.1.1 PRODUCT PRICING 58
4.1.2 INGREDIENTS 58
4.1.3 AUTHENTICITY OF PRODUCT 58
4.2 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 59
4.3 INDUSTRY TRENDS AND FUTURE PERSPECTIVE 60
4.3.1 GROWING DEMAND FOR NATURAL ADDITIVES 60
4.3.2 MANUFACTURERS OFFERING CERTIFIED FEED SUPPLEMENTS 60
4.3.3 BUSINESS EXPANSIONS THROUGH DIFFERENT STRATEGIC DECISIONS 60
4.4 FUTURE PERSPECTIVE 61
4.5 PORTER’S FIVE FORCES ANALYSIS FOR THE MIDDLE EAST & AFRICA PHYTOGENIC FEED ADDITIVES MARKET 62
4.6 SUPPLY CHAIN ANALYSIS 65
4.6.1 RAW MATERIAL PROCUREMENT & MANUFACTURING 65
4.6.2 DISTRIBUTION 65
4.6.3 END USERS 66
4.7 TECHNOLOGICAL ADVANCEMENT 66
4.8 VALUE CHAIN ANALYSIS: MIDDLE EAST & AFRICA PHYTOGENIC FEED ADDITIVES MARKET 67
5 PRICING INDEX 68
6 PRODUCTION CAPACITY OF KEY MANUFACTURERS 69
7 REGULATORY FRAMEWORK AND GUIDELINES 70
8 IMPACT OF ECONOMIC SLOWDOWN ON THE MARKET 72
8.1 IMPACT ON PRICE 72
8.2 IMPACT ON SUPPLY CHAIN 72
8.3 IMPACT ON SHIPMENT 72
8.4 IMPACT ON COMPANY'S STRATEGIC DECISIONS 73
9 BRAND OUTLOOK 74
10 MARKET OVERVIEW 77
10.1 DRIVERS 79
10.1.1 SURGING DEMAND FOR NATURAL FEED ADDITIVES 79
10.1.2 INCREASE IN THE CONSUMPTION OF ANIMAL PROTEIN 79
10.1.3 STRINGENT REGULATIONS ON ANTIBIOTIC FEED ADDITIVES 80
10.1.4 ESCALATING CONCERN REGARDING ANIMAL WEALTH 81
10.2 RESTRAINTS 82
10.2.1 AVAILABILITY OF ESTABLISHED ALTERNATIVES FOR FEED ADDITIVES 82
10.2.2 HIGHER-END PRODUCT PRICES CAUSE LOW-PROFIT MARGIN 83
10.2.3 LIMITED R&D IN PHYTOGENIC FEED ADDITIVES 83
10.3 OPPORTUNITIES 84
10.3.1 RISING DEMAND FOR PHYTOGENIC FEED ADDITIVES IN AQUACULTURE AND PET FEEDS 84
10.3.2 MEDICINAL PROPERTIES OF HERBS AND SPICES 85
10.3.3 GROWING DEMAND FOR ORGANIC MEAT 85
10.4 CHALLENGES 86
10.4.1 AVAILABILITY AND VOLATILITY OF ORGANIC RAW MATERIALS 86
10.4.2 THE PREVALENCE OF ADULTERATION AND SIDE EFFECTS OF PHYTOGENIC MATERIALS 86
11 MIDDLE EAST & AFRICA PHYTOGENIC FEED ADDITIVES MARKET, BY REGION 87
11.1 MIDDLE EAST AND AFRICA 88
11.1.1 SOUTH AFRICA 98
11.1.2 SAUDI ARABIA 103
11.1.3 U.A.E. 108
11.1.4 KUWAIT 113
11.1.5 OMAN 118
11.1.6 QATAR 123
11.1.7 REST OF MIDDLE EAST AND AFRICA 128
12 COMPANY LANDSCAPE 129
12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 129
13 SWOT 130
14 COMPANY PROFILE 131
14.1 CARGILL, INCORPORATED 131
14.1.1 COMPANY SNAPSHOT 131
14.1.2 REVENUE ANALYSIS 131
14.1.3 COMPANY SHARE ANALYSIS 132
14.1.4 PRODUCT PORTFOLIO 132
14.1.5 RECENT DEVELOPMENT 132
14.2 DSM 133
14.2.1 COMPANY SNAPSHOT 133
14.2.2 REVENUE ANALYSIS 133
14.2.3 COMPANY SHARE ANALYSIS 134
14.2.4 PRODUCT PORTFOLIO 134
14.2.5 RECENT DEVELOPMENTS 135
14.3 KEMIN INDUSTRIES, INC. 136
14.3.1 COMPANY SNAPSHOT 136
14.3.2 COMPANY SHARE ANALYSIS 136
14.3.3 PRODUCT PORTFOLIO 137
14.3.4 RECENT DEVELOPMENT 137
14.4 ADM 138
14.4.1 COMPANY SNAPSHOT 138
14.4.2 REVENUE ANALYSIS 138
14.4.3 COMPANY SHARE ANALYSIS 139
14.4.4 PRODUCT PORTFOLIO 139
14.4.5 RECENT DEVELOPMENTS 139
14.5 NUTRECO 140
14.5.1 COMPANY SNAPSHOT 140
14.5.2 COMPANY SHARE ANALYSIS 140
14.5.3 PRODUCT PORTFOLIO 141
14.5.4 RECENT DEVELOPMENT 141
14.6 BRITISH HORSE FEEDS 142
14.6.1 COMPANY SNAPSHOT 142
14.6.2 PRODUCT PORTFOLIO 142
14.6.3 RECENT DEVELOPMENT 142
14.7 CUSTOMER DOSTOFARM GMBH 143
14.7.1 COMPANY SNAPSHOT 143
14.7.2 PRODUCT PORTFOLIO 143
14.7.3 RECENT DEVELOPMENT 144
14.8 GLAMAC INTERNATIONAL PRIVATE LIMITED 145
14.8.1 COMPANY SNAPSHOT 145
14.8.2 PRODUCT PORTFOLIO 145
14.8.3 RECENT DEVELOPMENT 145
14.9 HIMALAYA WELLNESS COMPANY 146
14.9.1 COMPANY SNAPSHOT 146
14.9.2 PRODUCT PORTFOLIO 146
14.9.3 RECENT DEVELOPMENTS 146
14.10 IGUSOL 147
14.10.1 COMPANY SNAPSHOT 147
14.10.2 PRODUCT PORTFOLIO 147
14.10.3 RECENT DEVELOPMENTS 147
14.11 INDIAN HERBS 148
14.11.1 COMPANY SNAPSHOT 148
14.11.2 PRODUCT PORTFOLIO 148
14.11.3 RECENT DEVELOPMENT 148
14.12 MIAVIT GMBH 149
14.12.1 COMPANY SNAPSHOT 149
14.12.2 PRODUCT PORTFOLIO 149
14.12.3 RECENT DEVELOPMENT 149
14.13 NATURAL REMEDIES 150
14.13.1 COMPANY SNAPSHOT 150
14.13.2 PRODUCT PORTFOLIO 150
14.13.3 RECENT DEVELOPMENT 151
14.14 NOR-FEED 152
14.14.1 COMPANY SNAPSHOT 152
14.14.2 PRODUCT PORTFOLIO 152
14.14.3 RECENT DEVELOPMENT 152
14.15 ORFFA 153
14.15.1 COMPANY SNAPSHOT 153
14.15.2 PRODUCT PORTFOLIO 153
14.15.3 RECENT DEVELOPMENTS 153
14.16 PHYTOBIOTICS FUTTERZUSATZSTOFFE GMBH 154
14.16.1 COMPANY SNAPSHOT 154
14.16.2 PRODUCT PORTFOLIO 154
14.16.3 RECENT DEVELOPMENT 154
14.17 SILVATEAM S.P.A. 155
14.17.1 COMPANY SNAPSHOT 155
14.17.2 PRODUCT PORTFOLIO 155
14.17.3 RECENT DEVELOPMENT 155
14.18 TEGASA 156
14.18.1 COMPANY SNAPSHOT 156
14.18.2 PRODUCT PORTFOLIO 156
14.18.3 RECENT DEVELOPMENTS 156
14.19 VINAYAK INGREDIENTS INDIA 157
14.19.1 COMPANY SNAPSHOT 157
14.19.2 PRODUCT PORTFOLIO 157
14.19.3 RECENT DEVELOPMENT 157
15 QUESTIONNAIRE 158
16 RELATED REPORTS 161